BRITISH MEDICAL JOURNAL VOLUME 290 16 MARCH 1985 815 concentration when initiating treatment with continuous subcutaneous insulin infusion or multiple injections. We do not know whether this will occur if the blood glucose concentration is reduced at a slower rate. So far we have examined the effect of lowering the blood glucose concentration over several months, and after the initial deterioration retinopathy seems to improve. The study is continuing to see if this improvement rcmains. This study showed no major difference in efficacy between sodium valproate and phenytoin in adults with recent onset of epilepsy, irrespective of the type of seizures that the patient suffered.
Introduction
The overall prognosis for the remission of epilepsy appears good, up to 70C> of patients in a community based study achieving long term remission of their epilepsy,' compared with the more pessimistic outlook for patients drawn from hospital based popuiations with chronic epilepsy, in whom roughly 300o achieve remission.2 The more optimistic outlook is supported by several studies of previously untreated patients, which suggest a high rate of success irrespective of which single anticonvulsant drug is used. - The success of monotherapy in these studies demands a serious appraisal of which single anticonvulsant drug should be prescribed first to the patient presenting with epilepsy,7a and the need for carefully controlled, long term comparisons of anticonvulsant drugs is plain. 8 We report the results of a randomised, controlled clinical trial comparing the efficacy of sodium valproate and phenytoin in newly diagnosed adult epileptic patients followed up for between two and four years. Possibly the difficulty in detecting differences is due to the fact that the outcome for patients presenting with epilepsy is as much determined by natural history as by the drug treatment.
Thus most patients with only tonic-clonic seizures may become seizure free when treated with drugs even if these are of relatively low anticonvulsant potency. Some patients with partial seizures are resistant to any known anticonvulsant. There may be relatively few patients within a population of previously untreated epileptics in whom the potency and dosage of the drug will be critical in determining the response. Clearly if these patients could be defined they would represent a valuable population for study. Probably, therefore, the initial choice of anticonvulsant is more likely to be determined by relative toxicity than efficacy. Both drugs used in this study possessed dose related toxicityvalproate giving rise to tremor, alopecia, weight gain, and mental change with irritability and occasionally frank confusion,'2 [4] [5] [6] [7] Alkaline phosphatase (U '1) 66 IgA (g 1) There are few studies of the factors predicting the outcome of treatment in previously untreated patients. It is therefore of interest that the most dominant factor in outcome in both this study and that of Shorvon and Reynolds'5 was the history of partial seizures. Shorvon and Reynolds also found that the presence of a neurological, psychiatric, or social disability had an adverse effect on prognosis. We did not find this to be the case, possibly due to the difference in definitions used.
Overall, there seems little evidence of any major difference in efficacy between valproate and phenytoin in adult patients with recent onset of epilepsy, irrespective of the type of seizures that the patients suffered. This study does not disclose any difference in the symptoms of toxicity between the two drugs. Although the five cases of early idiosyncratic reactions which required drug withdrawal were all in the phenytoin group, this was not statistically significant at the 5%fO level. The unusual pharmacokinetic properties of phenytoin make it a more difficult drug for routine use, necessitating small dosage increments and frequent assays of serum drug concentration. In comparison, the relation between dose and serum concentration for valproate is linear, and regular blood monitoring of monotherapy does not seem to be critical. In women patients of childbearing age the choice of anticonvulsant drug remains difficult since both drugs appear to be teratogenic. '6 SHORT REPORTS Necrotising tongue and skin lesions in temporal arteritis: follow up of a case with a possible iatrogenic factor Temporal arteritis is a generalised vascular disease characterised by formation of granulomas (giant cell arteritis) which gradually constrict the lumen.' Arteries of medium and small size are those mainly affected, the site of predilection being within the cranial vascular territory. Cases with necrotising lesions of the scalp, skin, and tongue have been reported, probably resulting from massive disease of branches of the external carotid artery. We describe these complications in a patient with histologically proved disease2 and review published work to see how often they have been reported and under which circumstances they occurred.
Case report
A previously well 69 year old woman was admitted to hospital with a two month history of muscular pain, particularly in the shoulders, neck, and jaw. On examination she appeared fit and did not have headache or visual disturbances. The temporal arteries were slightly tender. Pulsation was normal. Sedimentation rate and plasma fibrinogen concentration were substantially increased. Ophthalmological findings were normal. A biopsy sample was taken from the right temporal artery under local anaesthetic containing a vasoconstrictor. Six hours later she complained of hypoaesthesia of the tongue and interior right side of the jaw and impaired movement of the tongue. A nasogastric tube was inserted because of difficulty with swallowing. She was given large doses of corticosteroids and improved within 24-48 hours.
The histological picture was giant cell arteritis. During the following days she developed anaesthesia of the right lower lip, inferior gingiva, and tongue, which became cyanotic. After nine days most of the tongue was necrotic together with the right lower lip. Tracheostomy was performed to prevent aspiration of the sloughing tongue. Revision of the tongue was postponed until demarcation had taken place six weeks later. Most of the alveolar process of the mandible was also necrotic. In addition, she developed necrotic lesions on the scalp, which were left to heal spontaneously.
The necrotic area of the right lower lip healed with severe shrinkage of the lip and fixation to the floor of the mouth. The lip was corrected by an Abbe operation and two months later a sulcoplasty was performed with a free graft of split skin. The patient was given a new denture for the lower jaw. Later the prosthetic treatment was completed with a tongue obturator fixed to a palatal plate. By these means she could speak adequately. Four months later the patient was in excellent health and the tracheostomy was closed. Problems with swallowing still necessitated a feeding tube, but after a year this was removed; she remained, however, able to take only a blended diet. She was followed up regularly as an outpatient for five and a half years and felt well taking a continual low dose of prednisone (5 mg daily).
Comment
Forty nine cases of necrotising lesions of the scalp, facial skin, and tongue have been reported, and in 29 of these there was histological proof of giant cell arteritis. In two of these cases the necrotising lesions within the cranial vascular territory developed shortly after biopsy under local anaesthesia. 3 Plainly, necrotising lesions may develop spontaneously in cases of advanced vascular changes of a constrictive-thrombotic nature. It seems reasonable to assume that tissues relying on a critical blood supply may undergo necrosis after an arterial spasm, retrograde in character, with thrombotic occlusion of all collateral and communicating vessels triggered by the vasoconstrictor in a local anaesthetic. Our patient showed symptoms from the cranial vascular territory with pain in the neck and jaw. The diagnosis was plain clinically, and the delay in instituting steroid treatment was probably an important factor in the development of severe necrosis.
